pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,440 catalysts · 5,159 phase readout · 2,342 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 47 catalysts2026-07-30: 13 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: filing×type: phase readout×type: earnings×clear all
type
  • phase readout5,159
  • 8k filing2,342
  • pdufa316
  • earnings275
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Ophthalmology5

    Date TBD

    50
    ›NOT_YET_RECRUITINGphase readoutNCT07653204: Contactless Ultrasound Data Acquisition in Emergency Departments to Discriminate the Origin of Dyspnea and Chest Pain

    Sponsor: Austral Diagnostics. Phase: . Conditions: Dyspnea, Chest Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06698406: Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale

    Sponsor: Benno Rehberg-Klug. Phase: . Conditions: Pain, Chronic

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04479306: Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06092216: Spesolimab in Pyoderma Gangrenosum

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: PHASE2. Conditions: Pyoderma Gangrenosum

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07274514: Virtual Reality on Balance of Parkinson's Disease

    Sponsor: Instituto de Investigación Sanitaria Aragón. Phase: NA. Conditions: Parkinson Disease (PD), Immersive Virtual Reality, Physical Therapy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06045806: A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

    Sponsor: Celgene. Phase: PHASE3. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04506606: Cardiac Rehab Effects in HFpEF

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Heart Failure With Preserved Ejection Fraction

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05413304: Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis

    Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Glioma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06841614: EBOla Post-Exposure Prophylaxis

    Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE3. Conditions: Ebola Virus Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07485114: Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

    Sponsor: Daniel Keizman. Phase: . Conditions: Renal Cell Carcinoma (Kidney Cancer), Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Transitional Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04120714: Efficacy of Transcranial Direct Current Stimulation (tDCS) in Patients Suffering From Pathological Use of Internet Gaming

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: NA. Conditions: Pathological Use of Internet Games

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07027306: The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

    Sponsor: AO Foundation, AO Spine. Phase: . Conditions: Osteoporotic Fractures, Osteoporosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06860516: HLA Demographics Study in Adults With Type 1 Diabetes

    Sponsor: GentiBio, Inc. Phase: . Conditions: Diabetes Mellitus, Type I

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07700316: Compare the Effect of Radiofrequency (TECAR) and Ultrasound on Sensation, Hand Dexterity, and Quality of Life in Patients With Carpal Tunnel Syndrome.

    Sponsor: Delta University for Science and Technology. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04198116: Combining Varenicline and Guanfacine for Smoking Cessation

    Sponsor: Yale University. Phase: PHASE2. Conditions: Smoking Cessation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06666504: The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study

    Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: . Conditions: Severe Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05696704: Telehealth to Reduce Mental Health in Family Caregivers

    Sponsor: Texas Tech University. Phase: NA. Conditions: Mental Health Issue, Grief, Burden, Caregiver

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07048314: Stem Cells for Erectile Dysfunction Post RALP

    Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Erectile Dysfunction, Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07344116: Hepatobiliary and Pancreatic Tumor Biobank

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: . Conditions: Hepotacellular Carcinoma, Cholangiocarcinoma, Pancreatic Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07451106: Exploring Clinical Utility of Wearables for the Bladder in Pelvic Health Physical Therapy Clinics

    Sponsor: University of California, San Francisco. Phase: . Conditions: Postpartum Bladder Dysfunction, Post-prostatectomy Bladder Dysfunction, Bladder Dysfunction

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03510104: Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

    Sponsor: Meryx, Inc.. Phase: PHASE1. Conditions: Advanced Cancer, Metastatic Cancer, Neoplasms, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05886504: Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users

    Sponsor: ANRS, Emerging Infectious Diseases. Phase: NA. Conditions: Psychiatric Disorder, Drug Use

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06849804: Comparing the Efficacy of Ultrasound Guided Erector Spinae Plane Block, Ultrasound Guided Caudal Block, and Local Infiltration for Postoperative Pain Control in Pediatric Patients Undergoing Unilateral Inguinal Hernia Repair as a Day-Case Surgeries: A Randomized Controlled Trial

    Sponsor: Tanta University. Phase: NA. Conditions: Analgesia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626516: Tebentafusp-tebn With LDT in Metastatic UM

    Sponsor: Thomas Jefferson University. Phase: PHASE1. Conditions: Metastatic Uveal Melanoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07701616: Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder

    Sponsor: Central South University. Phase: NA. Conditions: Obsessive-Compulsive Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06030206: Lung Transplant READY CF 2: A Multi-site RCT

    Sponsor: University of Washington. Phase: NA. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06459024: Master Framework For Relapse or Refractory Acute Myeloid Leukemia

    Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS. Phase: . Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07440823: Effects of Accentuated Eccentric Versus Concentric Training in Fast Bowlers

    Sponsor: Riphah International University. Phase: NA. Conditions: Sports Physical Therapy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05447923: Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Colorectal Carcinoma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04030559: Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects

    Sponsor: University of California, Davis. Phase: PHASE2. Conditions: ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation, BRIP1 Gene Mutation, CDK12 Gene Mutation, CHEK1 Gene Mutation, CHEK2 Gene Mutation, DNA Damage Response Gene Mutation, DNA Repair Gene Mutation, FANCA Gene Mutation, FANCD2 Gene Mutation, FANCL Gene Mutation, GEN1 Gene Mutation, NBN Gene Mutation, Prostate Carcinoma, RAD51 Gene Mutation, RAD51C Gene Mutation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05398380: Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research

    Sponsor: Hospital Vall d'Hebron. Phase: NA. Conditions: Colorectal Cancer, Liver Metastases, Genetic Change

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT06713798: Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures

    Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: PHASE2. Conditions: Metastatic Cancer Lung, Advanced Lung Cancer, CBNPC Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06041763: Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Meniscus Tear

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07525063: Pain & Reward Neuromodulation of CNS Circuits

    Sponsor: Duke University. Phase: NA. Conditions: Fibromyalgia Syndrome, Fibromyalgia, Chronic Pain and Fatigue

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06501963: Revealing Protective Immunity to Influenza Using Systems Immunology

    Sponsor: Emory University. Phase: PHASE4. Conditions: Influenza

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06982521: Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

    Sponsor: Relay Therapeutics, Inc.. Phase: PHASE3. Conditions: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06868979: Optical Imaging in X-linked Disorders.

    Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Fragile X Syndrome (FXS), Creatine Transporter Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04016246: Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation.

    Sponsor: University Hospital, Grenoble. Phase: PHASE3. Conditions: Respiratory Distress Syndrome in Premature Infant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05236062: Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

    Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07557446: A Dose REgimen-Finding Study of AGA2115 in Chinese Patients With Osteogenesis ImpeRfecta (EIR)

    Sponsor: Angitia Biopharmaceuticals Guangzhou Limited. Phase: PHASE2. Conditions: Osteogenesis Imperfecta (OI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07236099: Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis

    Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.. Phase: PHASE2. Conditions: Prurigo Nodularis (PN)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06641999: Evaluating How a Tinnitus Implant Affects Tinnitus Loudness in Adults With Chronic Tinnitus and Varying Levels of Hearing Loss

    Sponsor: Cochlear. Phase: NA. Conditions: Tinnitus, Hearing Loss, Bilateral or Unilateral, Normal Hearing

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06620432: High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean

    Sponsor: Fundacion Clinica Valle del Lili. Phase: NA. Conditions: Placenta Accreta Spectrum

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07568132: Efferon LPS Hemoadsorption in in Patients With Thermal Burns

    Sponsor: Efferon JSC. Phase: NA. Conditions: Burns

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04216732: Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management

    Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Advanced Thyroid Gland Medullary Carcinoma, Stage III Thyroid Gland Medullary Carcinoma AJCC v8, Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07704398: Effect of Corticosteroid Injection in Symptomatic Pulpitis Cases

    Sponsor: Istanbul Medipol University Hospital. Phase: NA. Conditions: Periapical Periodontitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07707063: This a Clinical Trial to Evaluate the Efficacy of I-PRF, Povidone-Iodine and Laser as Adjuncts to Non-surgical Periodontal Treatment in Smokers and Non-Smokers Periodontitis Patients

    Sponsor: Military Hospital of Tunis. Phase: PHASE4. Conditions: Periodontitis, Smokers, Non Smokers, Periodontal Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06954363: Effectiveness of Muscle Energy Techniques and Mulligan Mobilization Along With Conventional Physical Therapy in Knee Joint Osteoarthritis Patients

    Sponsor: Khyber Medical University Peshawar. Phase: NA. Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07649187: Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG

    Sponsor: Ming-Hsing Chang. Phase: NA. Conditions: Myasthenia Gravis, Depression, Thymoma, Depression and Quality of Life, Quality of Life, Activities of Daily Living

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06100146: Effectiveness of Fortification With Folic Acid and Vitamin B12 Among Teenage Girls

    Sponsor: University Ghent. Phase: NA. Conditions: Folate Deficiency, Vitamin B 12 Deficiency, Anemia, Megaloblastic, Cognitive Development, Depressive Symptoms

    full page →ctgov ↗
    ← prev
    page 95 of 109
    next →